Glinet (Glimepiride)

Glinet is an oral antidiabetic medication containing Glimepiride, primarily used to manage blood sugar levels in patients with type 2 diabetes. The brand was developed and is manufactured by Minapharm Pharmaceuticals, a leading pharmaceutical company in Egypt and the Middle East. Headquartered in Cairo, Minapharm is known for its extensive manufacturing capabilities, including biological and chemical therapeutics.

While Minapharm is the primary brand owner and manufacturer within the Egyptian market, the company maintains significant international partnerships, most notably with global biotech leaders. The ownership remains centrally managed through Minapharm's corporate structure in Egypt, serving both the local market and several international export regions. The product represents a cost-effective localized generic version of the global standard for glimepiride-based treatments.